What Verdica's 850 score means for MANCHESTER COMMONS OF PRESBYTERIAN SENIORCARE
Verdica's composite score of 850 out of 850 places MANCHESTER COMMONS OF PRESBYTERIAN SENIORCARE in the "excellent" band (800–850), the highest performance tier. This score reflects aggregated compliance data from two major regulatory dimensions: inspection results and quality measures tracked by the Centers for Medicare & Medicaid Services (CMS). A score at this level indicates that the provider has demonstrated consistent adherence to federal and state healthcare standards based on the most recent available inspection findings and reported quality outcomes.
Readers should understand that this score is not a subjective endorsement but rather a quantitative snapshot of documented regulatory performance. An 850 composite reflects strong results across all measured domains. However, it is important to note that no independent customer reviews are currently indexed for this entity in Verdica's database, so this assessment is based solely on regulatory data, not patient or family feedback.
How the sub-scores break down
Inspection & Deficiencies: 850
This sub-score reflects findings from state and federal inspection visits conducted under CMS licensing and certification protocols. A perfect score in this dimension means the provider has not accumulated significant deficiencies—violations of federal or state healthcare regulations—during recent surveys. Deficiencies range in severity (from minor to immediate jeopardy), and inspectors look for compliance with requirements around resident care, staffing, safety, infection control, and administration. A high score here signals that on-site review teams found minimal or no substantive violations of operational standards.
Quality Measures: 850
This sub-score is based on standardized quality metrics reported by the provider to CMS, typically covering outcomes such as infection rates, hospitalization rates, readmission rates, and staffing levels. These measures are designed to reflect the effectiveness of care delivery and resident safety. A top score in this dimension indicates that the provider's reported outcomes align with or exceed national benchmarks and regulatory thresholds for the provider type.
What regulators in PA track for healthcare providers
Pennsylvania-licensed healthcare providers are subject to ongoing CMS inspections and must report quality data to federal registries. Inspectors evaluate compliance across multiple dimensions: resident rights and safety, quality of care, nursing services adequacy, infection prevention, medication management, environmental safety, and administrative competency. Violations—called deficiencies—can range from isolated lapses to systemic failures and are categorized by scope and severity.
Quality measures tracked by CMS typically include rates of pressure injuries, falls, infections (such as urinary tract and antibiotic-resistant organisms), unnecessary antibiotic use, staff turnover, and vaccination rates. Providers must submit this data regularly. CMS also tracks enforcement actions: citations, monetary penalties, or loss-of-license recommendations can materially lower a provider's compliance standing.
The inspection frequency and intensity depend on provider type and prior compliance history. Providers with clean records typically face standard surveys; those with documented problems face more frequent revisits. All inspection reports and quality data become part of the public record and feed into oversight databases.
A score of 850 across these dimensions suggests recent inspection cycles found no serious violations and that the provider's self-reported quality metrics are within acceptable to strong ranges relative to regulatory benchmarks.
Bottom line
MANCHESTER COMMONS OF PRESBYTERIAN SENIORCARE is rated in the excellent compliance band based on current regulatory inspection and quality data. Before making a business or personal care decision, cross-check current CMS inspection reports, review recent quality measure trends on the official CMS website, and seek out recent patient and family feedback to supplement this regulatory view.